Company strategies for designing non-clinical safety evaluation programmes: Results of a CMR International survey

  • Susan A. Griffiths
Chapter
Part of the CMR International Workshop Series book series (CMRW)

Abstract

1. The type of studies included in non-clinical safety evaluation programmes for pharmaceutical products of biotechnology and the reasons for their inclusion were identified through a questionnaire-based survey, in response to industry’s concern that certain studies are being inappropriately included.

Keywords

Pharmaceutical Product Transgenic Animal Safety Evaluation Product Class Human Peripheral Lymphocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Griffiths SA, Ashton GA and Lumley CE (1995). Non-clinical Safety Testing of Products of Biotechnology: Issues of Concern. CMR International Report, CMR95-63R, December 1995.Google Scholar
  2. Scrip (1996). Pharmaceutical Company League Tables. PJB Publications Ltd, October 1996.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Susan A. Griffiths

There are no affiliations available

Personalised recommendations